Quarterly Put Option Transactions in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC). The information is specifically focused on institutions that hold put options of Revance Therapeutics, Inc..
Puts Purchased
Puts Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | — | 32,500 | 0 | 32,500 | -32,500 | |||
| Q4 2021 | 46,200 | 438,400 | 484,600 | 800 | 0 | 800 | 483,800 | |
| Q1 2022 | 62,600 | 100,000 | 162,600 | 14,700 | 55,500 | 70,200 | 92,400 | |
| Q2 2022 | 258,900 | 0 | 258,900 | 2,700 | 0 | 2,700 | 256,200 | |
| Q3 2022 | 1,341,900 | 1,089,700 | 2,431,600 | 10,700 | 0 | 10,700 | 2,420,900 | |
| Q4 2022 | 55,200 | 10,000 | 65,200 | 476,900 | 0 | 476,900 | -411,700 | |
| Q1 2023 | 28,900 | 80,500 | 109,400 | 870,800 | 0 | 870,800 | -761,400 | |
| Q2 2023 | 69,400 | 48,000 | 117,400 | 25,500 | 0 | 25,500 | 91,900 | |
| Q3 2023 | 174,900 | 8,200 | 183,100 | 12,800 | 0 | 12,800 | 170,300 | |
| Q4 2023 | 86,000 | 5,000 | 91,000 | 225,400 | 0 | 225,400 | -134,400 | |
| Q1 2024 | 144,000 | 45,700 | 189,700 | 14,100 | 0 | 14,100 | 175,600 | |
| Q2 2024 | 1,100 | 0 | 1,100 | 256,900 | 0 | 256,900 | -255,800 | |
| Q3 2024 | 4,000 | 818,310 | 822,310 | 36,100 | 0 | 36,100 | 786,210 | |